| Nome |
# |
|
Egg-Independent Influenza Vaccines and Vaccine Candidates, file e0feeaa7-a088-44d2-e053-6605fe0a8db0
|
191
|
|
Toxoplasma gondii in women of childbearing age and during pregnancy: seroprevalence study in Central and Southern Italy from 2013 to 2017, file e0feeaa8-6014-44d2-e053-6605fe0a8db0
|
170
|
|
Influenza D virus: Serological evidence in the Italian population from 2005 to 2017, file e0feeaa8-a94c-44d2-e053-6605fe0a8db0
|
159
|
|
Influenza vaccines: Evaluation of the safety profile, file e0feeaa7-a1e3-44d2-e053-6605fe0a8db0
|
146
|
|
Emerging influenza strains in the last two decades: A threat of a new pandemic?, file e0feeaa7-a678-44d2-e053-6605fe0a8db0
|
144
|
|
Influenza anti-stalk antibodies: Development of a new method for the evaluation of the immune responses to universal vaccine, file e0feeaa8-add9-44d2-e053-6605fe0a8db0
|
142
|
|
How to assess the effectiveness of nasal influenza vaccines? Role and measurement of sIgA in mucosal secretions, file e0feeaa8-2bca-44d2-e053-6605fe0a8db0
|
135
|
|
Elimination of congenital rubella: a seroprevalence study of pregnant women and women of childbearing age in Italy, file e0feeaa8-6015-44d2-e053-6605fe0a8db0
|
135
|
|
Recombinant Haemagglutinin Derived From the Ciliated Protozoan Tetrahymena thermophila Is Protective Against Influenza Infection, file e0feeaa8-a21f-44d2-e053-6605fe0a8db0
|
134
|
|
Measles in pregnancy: a threat for Italian women?, file e0feeaa8-a220-44d2-e053-6605fe0a8db0
|
124
|
|
Pertussis over two decades: Seroepidemiological study in a large population of the Siena Province, Tuscany Region, Central Italy, file e0feeaa8-6413-44d2-e053-6605fe0a8db0
|
123
|
|
Overview of serological techniques for influenza vaccine evaluation: Past, Present and Future, file e0feeaa7-a24b-44d2-e053-6605fe0a8db0
|
115
|
|
Comparison of hemagglutination inhibition, single radial hemolysis, virus neutralization assays, and ELISA to detect antibody levels against seasonal influenza viruses, file e0feeaa7-f033-44d2-e053-6605fe0a8db0
|
99
|
|
"OKKIO alla salute 2014" results from the Tuscan sample, file e0feeaa7-a5b8-44d2-e053-6605fe0a8db0
|
89
|
|
Influenza immunology evaluation and correlates of protection: a focus on vaccines, file e0feeaab-be5c-44d2-e053-6605fe0a8db0
|
87
|
|
Epidemiology of herpes simplex virus type 1 and 2 in Italy: a seroprevalence study from 2000 to 2014, file e0feeaa7-a1eb-44d2-e053-6605fe0a8db0
|
70
|
|
Serologically-Based Evaluation of Cross-Protection Antibody Responses among Different A(H1N1) Influenza Strains, file e0feeaa9-5e04-44d2-e053-6605fe0a8db0
|
69
|
|
Evaluation of SARS‐CoV‐2 neutralizing antibodies using a CPE‐based colorimetric live virus micro‐neutralization assay in human serum samples, file e0feeaa9-818d-44d2-e053-6605fe0a8db0
|
67
|
|
Surveillance for severe acute respiratory infections among hospitalized subjects from 2015/2016 to 2019/2020 seasons in tuscany, Italy, file e0feeaaa-5332-44d2-e053-6605fe0a8db0
|
61
|
|
null, file e0feeaa6-36f2-44d2-e053-6605fe0a8db0
|
56
|
|
Evaluation of varicella immunity during pregnancy in apulia region, southern italy, file e0feeaa9-76ca-44d2-e053-6605fe0a8db0
|
54
|
|
Seroprevalence of hepatitis e virus in forestry workers from trentino-alto adige region (Northern Italy), file e0feeaa9-2a8b-44d2-e053-6605fe0a8db0
|
51
|
|
Impact of erythrocyte species on assays for influenza serology, file e0feeaa7-a190-44d2-e053-6605fe0a8db0
|
48
|
|
Water and air ozone treatment as an alternative sanitizing technology, file e0feeaa7-a1e8-44d2-e053-6605fe0a8db0
|
37
|
|
A serological investigation in Southern Italy: was SARS-CoV-2 circulating in late 2019?, file e0feeaab-cb13-44d2-e053-6605fe0a8db0
|
31
|
|
SARS-CoV-2 epidemiological trend before vaccination era: a seroprevalence study in Apulia, Southern Italy, in 2020, file da6c62ef-026d-4865-a2eb-94e1df08bb71
|
21
|
|
Comparative analyses of SARS-CoV-2 binding (IgG, IgM, IgA) and neutralizing antibodies from human serum samples, file 90213800-72dc-4cd9-925c-00cc47edff67
|
20
|
|
Detection of antibodies against influenza D virus in swine veterinarians in Italy in 2004, file 42ef957e-b966-4b81-8af7-501177334582
|
18
|
|
Trend of Correlations between Psychological Symptoms and Socioeconomic Inequalities among Italian Adolescents: Cross-Sectional Study from 2006 to 2018 in Tuscany Region, file ce6df555-4117-4988-9d25-8ae1fd22360d
|
16
|
|
Neutralizing activity of African lineage Zika virus immune sera towards Asian lineage, file a8f26901-f358-48a2-bfa8-5e2388390e27
|
14
|
|
In vitro virucidal activity of mouthwashes on SARS-CoV-2, file a235d0f0-fc48-4470-8c2b-a6fde85c0dc9
|
12
|
|
Virucidal Activity of Lemon Essential Oil against Feline Calicivirus Used as Surrogate for Norovirus, file 4888d96b-1223-40e5-aced-83ebc5431c26
|
11
|
|
Immunogenicity of Calvenza-03 EIV/EHV® Vaccine in Horses: Comparative In Vivo Study, file 139e3939-bbaf-4da0-94b2-783154373e9b
|
6
|
|
Characterization of antibody response in asymptomatic and symptomatic SARS-CoV-2 infection, file 34daf04a-216a-45e0-9932-c04da2c134e3
|
6
|
|
Correlation of Influenza B Haemagglutination Inhibiton, Single-Radial Haemolysis and Pseudotype-Based Microneutralisation Assays for Immunogenicity Testing of Seasonal Vaccines, file 41b67ca9-de0a-4457-b0da-00b4348c8581
|
6
|
|
West Nile Virus Seroprevalence in the Italian Tuscany Region from 2016 to 2019, file d0439d92-e9d9-42d5-8a73-ac4de8e3ec5b
|
6
|
|
Assay Harmonization and Use of Biological Standards To Improve the Reproducibility of the Hemagglutination Inhibition Assay: a FLUCOP Collaborative Study, file 7dc46727-aea3-4efd-9abf-ae251a0669c3
|
4
|
|
COVID-19 Outbreak and BNT162b2 mRNA Vaccination Coverage in a Correctional Facility during Circulation of the SARS-CoV-2 Omicron BA.1 Variant in Italy, file aed8427f-b2d7-4dcc-83d7-f0ae9de2cb7f
|
4
|
|
Seroprevalence of antibodies to cytomegalovirus in pregnant women in the Apulia region (Italy), file c507c5cd-2220-47e1-b0ea-fc893d9b75d7
|
4
|
|
Evaluation of immune response to SARS-CoV-2 Omicron sublineages six months after different vaccination regimens in Italy, file 302687b0-568c-4468-a4ec-06210c57ebaf
|
3
|
|
Establishment and validation of a high-throughput micro-neutralization assay for respiratory syncytial virus (subtypes A and B), file 85ecdd06-716c-4b87-9a12-3cdc7c1a22bb
|
3
|
|
The burden of influenza and the role of influenza vaccination in adults aged 50-64 years: A summary of available evidence, file be50ad9f-6ff4-4cde-8595-aeceac72ec09
|
3
|
|
Virucidal activity in vitro of mouthwashes against a feline coronavirus type II, file e7b0e003-92b1-42ed-998b-577c045d5eac
|
3
|
|
Immune response to SARS-CoV-2 Omicron variant in patients and vaccinees following homologous and heterologous vaccinations, file ef3b9d52-0fa0-4c2a-bb67-b47aeb6917d8
|
3
|
|
Evaluation of Monkeypox- and Vaccinia virus-neutralizing antibodies in human serum samples after vaccination and natural infection, file 6a083519-4b20-4fa1-9dfe-49bbc64b3433
|
2
|
|
Retrospective Study Evaluating Seroprevalence of Hepatitis E Virus in Blood Donors and in Swine Veterinarians in Italy (2004), file e0feeaa6-39e8-44d2-e053-6605fe0a8db0
|
2
|
|
Evaluation of maternal perception of children's weight and body mass index in tuscany, Italy, file e0feeaa8-c705-44d2-e053-6605fe0a8db0
|
2
|
|
null, file e0feeaa9-79e6-44d2-e053-6605fe0a8db0
|
2
|
|
Cell culture-derived influenza vaccines from Vero cells: a new horizon for vaccine production, file e0feeaa4-f45a-44d2-e053-6605fe0a8db0
|
1
|
|
Immunogenicity, safety and tolerability of inactivated trivalent influenza vaccine in overweight and obese children, file e0feeaa6-3453-44d2-e053-6605fe0a8db0
|
1
|
|
Antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2, file e0feeaa6-553c-44d2-e053-6605fe0a8db0
|
1
|
|
Validation of Single Radial Haemolysis assay: A reliable method to measure antibodies against influenza viruses, file e0feeaa7-a24d-44d2-e053-6605fe0a8db0
|
1
|
|
Medicine use and recurrent complaints among 15-years-old adolescents in Tuscany, file e0feeaa8-1855-44d2-e053-6605fe0a8db0
|
1
|
|
Low prevalence of antibodies against pertussis in pregnant women in Italy, file e0feeaa8-597e-44d2-e053-6605fe0a8db0
|
1
|
|
Serum neutralizing activity against b.1.1.7, b.1.351, and p.1 sars-cov-2 variants of concern in hospitalized covid-19 patients, file e0feeaab-8b64-44d2-e053-6605fe0a8db0
|
1
|
| Totale |
2.715 |